Role of heme oxygenase in preserving vascular bioactive NO

Nitric Oxide - Biology and Chemistry

Volumn 23, Issue 4, 2010, Pages 251-257

  Pae, Hyun Ock ^a   Son, Yong ^a   Kim, Nam Ho ^b   Jeong, Hee Jong ^a   Chang, Ki Churl ^c   Chung, Hun Taeg ^d  

^a Wonkwang University School of Medicine   (South Korea)

^b Wonkwang University Hospital   (South Korea)

^c Gyeongsang National University School of Medicine   (South Korea)

^d University of Ulsan   (South Korea)

Author keywords

Bilirubin; Carbon monoxide; Endothelium; ENOS; Heme oxygenase 1; Nitric oxide

Indexed keywords

ANTIOXIDANT; CARBON MONOXIDE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FERRITIN; FERROUS ION; HEME OXYGENASE 1; I KAPPA B; LOW DENSITY LIPOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PICEATANNOL; PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SIMVASTATIN; TRANSCRIPTION FACTOR AP 1; XANTHINE OXIDASE;

ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BIOAVAILABILITY; CARDIOVASCULAR SYSTEM; CELL PROLIFERATION; CELL PROTECTION; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPERTENSION; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SMOOTH MUSCLE FIBER; THROMBOCYTE AGGREGATION; TRANSLATION INITIATION; VASODILATATION;

ANIMALS; HEME OXYGENASE-1; HUMANS; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PROTEIN KINASES; TRANSCRIPTION FACTORS;

EID: 77958150583     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2010.08.002     Document Type: Review

References (81)

1. Chatterjee A., Black S.M., Catravas J.D. Endothelial nitric oxide (NO) and its pathophysiologic regulation. Vascul. Pharmacol. 2008, 49:134-140.
2. Bauersachs J., Widder J.D. Endothelial dysfunction in heart failure. Pharmacol. Rep. 2008, 60:119-126.
3. Mungrue I.N., Husain M., Stewart D.J. The role of NOS in heart failure: lessons from murine genetic models. Heart Fail. Rev. 2002, 7:407-422.
4. Ricciardolo F.L., Sterk P.J., Gaston B., Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol. Rev. 2004, 84:731-765.
5. 2S) in inflammation. Arch. Pharm. Res. 2009, 32:1155-1162.
6. Napoli C., Ignarro L.J. Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases. Arch. Pharm. Res. 2009, 32:1103-1108.
7. Chung H.T., Pae H.O., Cha Y.N. Role of heme oxygenase-1 in vascular disease. Curr. Pharm. Des. 2008, 14:422-428.
8. Pae H.O., Kim EC E.C., Chung H.T. Integrative survival response evoked by heme oxygenase-1 and heme metabolites. J. Clin. Biochem. Nutr. 2008, 42:197-203.
9. Pae H.O., Lee Y.C., Chung H.T. Heme oxygenase-1 and carbon monoxide: emerging therapeutic targets in inflammation and allergy. Recent Pat. Inflamm. Allergy Drug Discov. 2008, 2:159-165.
10. Ryter S.W., Alam J., Choi A.M. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol. Rev. 2006, 86:583-650.
11. Peterson S.J., Frishman W.H., Abraham N.G. Targeting heme oxygenase: therapeutic implications for diseases of the cardiovascular system. Cardiol. Rev. 2009, 17:99-111.
12. Förstermann U. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat. Clin. Pract. Cardiovasc. Med. 2008, 5:338-349.
13. Wolin M.S., Abraham N.G. Heme oxygenase-1 inhibition of Nox oxidase activation is a microvascular endothelial antioxidant effect of NO. Hypertension 2006, 48:826-827.
14. Schulz R., Rassaf T., Massion P.B., Kelm M., Balligand J.L. Recent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis. Pharmacol. Ther. 2005, 108:225-256.
15. Abraham N.G., Kappas A. Heme oxygenase and the cardiovascular-renal system. Free Radic. Biol. Med. 2005, 39:1-25.
16. Ishikawa K. Heme oxygenase-1 against vascular insufficiency: roles of atherosclerotic disorders. Curr. Pharm. Des. 2003, 9:2489-2497.
17. Ishikawa K., Maruyama Y. Heme oxygenase as an intrinsic defense system in vascular wall: implication against atherogenesis. J. Atheroscler. Thromb. 2001, 8:63-70.
18. Peterson S.J., Kim D.H., Li M., Positano V., Vanella L., Rodella L.F., Piccolomini F., Puri N., Gastaldelli A., Kusmic C., L'Abbate A., Abraham N.G. The L-4F mimetic peptide prevents insulin resistance through increased levels of HO-1, pAMPK, and pAKT in obese mice. J. Lipid Res. 2009, 50:1293-1304.
19. Nicolai A., Li M., Kim D.H., Peterson S.J., Vanella L., Positano V., Gastaldelli A., Rezzani R., Rodella L.F., Drummond G., Kusmic C., L'Abbate A., Kappas A., Abraham N.G. Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats. Hypertension 2009, 53:508-515.
20. He J.Z., Ho J.J., Gingerich S., Courtman D.W., Marsden P.A., Ward M.E. Enhanced translation of heme oxygenase-2 preserves human endothelial cell viability during hypoxia. J. Biol. Chem. 2010, 285:9452-9461.
21. MacLeod A.K., McMahon M., Plummer S.M., Higgins L.G., Penning T.M., Igarashi K., Hayes J.D. Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds. Carcinogenesis 2009, 30:1571-1580.
22. Sakoda E., Igarashi K., Sun J., Kurisu K., Tashiro S. Regulation of heme oxygenase-1 by transcription factor Bach1 in the mouse brain. Neurosci. Lett. 2008, 440:160-165.
23. Alam J., Cook J.L. How many transcription factors does it take to turn on the heme oxygenase-1 gene?. Am. J. Respir. Cell Mol. Biol. 2007, 36:166-174.
24. Alam J., Den Z. Distal AP-1 binding sites mediate basal level enhancement and TPA induction of the mouse heme oxygenase-1 gene. J. Biol. Chem. 1992, 267:21894-21900.
25. Thorin-Trescases N., Thorin E. HO-1, a new target of PPARdelta with 'anti-atherogenic' properties: is it the one?. Cardiovasc. Res. 2010, 85:647-648.
26. Ali F., Ali N.S., Bauer A., Boyle J.J., Hamdulay S.S., Haskard D.O., Randi A.M., Mason J.C. PPARdelta and PGC1alpha act cooperatively to induce haem oxygenase-1 and enhance vascular endothelial cell resistance to stress. Cardiovasc. Res. 2010, 85:701-710.
27. Krönke G., Kadl A., Ikonomu E., Blüml S., Fürnkranz A., Sarembock I.J., Bochkov V.N., Exner M., Binder B.R., Leitinger N. Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1276-1282.
28. Geest C.R., Coffer P.J. MAPK signaling pathways in the regulation of hematopoiesis. J. Leukoc. Biol. 2009, 86:237-350.
29. Hong J.T., Yen J.H., Wang L., Lo Y.H., Chen Z.T., Wu M.J. Regulation of heme oxygenase-1 expression and MAPK pathways in response to kaempferol and rhamnocitrin in PC12 cells. Toxicol. Appl. Pharmacol. 2009, 237:59-68.
30. Hsu J.T., Kan W.H., Hsieh C.H., Choudhry M.A., Schwacha M.G., Bland K.I., Chaudry I.H. Mechanism of estrogen-mediated intestinal protection following trauma-hemorrhage: p38 MAPK-dependent upregulation of HO-1. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2008, 294:R1825-R1831.
31. Lim H.J., Lee K.S., Lee S., Park J.H., Choi H.E., Go S.H., Kwak H.J., Park H.Y. 15d-PGJ2 stimulates HO-1 expression through p38 MAP kinase and Nrf-2 pathway in rat vascular smooth muscle cells. Toxicol. Appl. Pharmacol. 2007, 223:20-27.
32. Yang X., Lee P.J., Long L., Trembath R.C., Morrell N.W. BMP4 induces HO-1 via a Smad-independent, p38MAPK-dependent pathway in pulmonary artery myocytes. Am. J. Respir. Cell Mol. Biol. 2007, 37:598-605.
33. Yao P., Nussler A., Liu L., Hao L., Song F., Schirmeier A., Nussler N. Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK/Nrf2 pathways. J. Hepatol. 2007, 47:253-261.
34. McNally S.J., Harrison E.M., Ross J.A., Garden O.J., Wigmore S.J. Curcumin induces heme oxygenase 1 through generation of reactive oxygen species, p38 activation and phosphatase inhibition. Int. J. Mol. Med. 2007, 19:165-172.
35. Cheng P.Y., Lee Y.M., Shih N.L., Chen Y.C., Yen M.H. Heme oxygenase-1 contributes to the cytoprotection of alpha-lipoic acid via activation of p44/42 mitogen-activated protein kinase in vascular smooth muscle cells. Free Radic. Biol. Med. 2006, 40:1313-1322.
36. Lee T.S., Chang C.C., Zhu Y., Shyy J.Y. Simvastatin induces heme oxygenase-1: a novel mechanism of vessel protection. Circulation 2004, 110:1296-1302.
37. Kiemer A.K., Bildner N., Weber N.C., Vollmar A.M. Characterization of heme oxygenase 1 (heat shock protein 32) induction by atrial natriuretic peptide in human endothelial cells. Endocrinology 2003, 144:802-812.
38. Fürst R., Blumenthal S.B., Kiemer A.K., Zahler S., Vollmar A.M. Nuclear factor-kappaB-independent anti-inflammatory action of salicylate in human endothelial cells: induction of heme oxygenase-1 by the c-jun N-terminal kinase/activator protein-1 pathway. J. Pharmacol. Exp. Ther. 2006, 318:389-394.
39. Anwar A.A., Li F.Y., Leake D.S., Ishii T., Mann G.E., Siow R.C. Induction of heme oxygenase 1 by moderately oxidized low-density lipoproteins in human vascular smooth muscle cells: role of mitogen-activated protein kinases and Nrf2. Free Radic. Biol. Med. 2005, 39:227-236.
40. Wung B.S., Hsu M.C., Wu C.C., Hsieh C.W. Piceatannol upregulates endothelial heme oxygenase-1 expression via novel protein kinase C and tyrosine kinase pathways. Pharmacol. Res. 2006, 53:113-122.
41. Hsieh C.Y., Hsiao H.Y., Wu W.Y., Liu C.A., Tsai Y.C., Chao Y.J., Wang D.L., Hsieh H.J. Regulation of shear-induced nuclear translocation of the Nrf2 transcription factor in endothelial cells. J. Biomed. Sci. 2009, 16:12.
42. Ryter S.W., Morse D., Choi A.M. Carbon monoxide and bilirubin: potential therapies for pulmonary/vascular injury and disease. Am. J. Respir. Cell Mol. Biol. 2007, 36:175-182.
43. Balla J., Vercellotti G.M., Jeney V., Yachie A., Varga Z., Jacob H.S., Eaton J.W., Balla G. Heme, heme oxygenase, and ferritin: how the vascular endothelium survives (and dies) in an iron-rich environment. Antioxid. Redox Signal. 2007, 9:2119-2137.
44. Stocker R. Antioxidant activities of bile pigments. Antioxid. Redox Signal. 2004, 6:841-849.
45. Kuhlencordt P.J., Gyurko R., Han F., Scherrer-Crosbie M., Aretz T.H., Hajjar R., Picard M.H., Huang P.L. Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation 2001, 104:448-454.
46. Chen A.F., Ren J., Miao C.Y. Nitric oxide synthase gene therapy for cardiovascular disease. Jpn. J. Pharmacol. 2002, 89:327-336.
47. Balligand J.I., Feron O., Dessy C. ENOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues. Physiol. Rev. 2009, 89:481-534.
48. Boon R.A., Horrevoets A.J. Key transcriptional regulators of the vasoprotective effects of shear stress. Hamostaseologie 2009, 29:39-43.
49. Sprague B., Chesler N.C., Magness R.R. Shear stress regulation of nitric oxide production in uterine and placental artery endothelial cells: experimental studies and hemodynamic models of shear stresses on endothelial cells. Int. J. Dev. Biol. 2010, 54:331-339.
50. Davis M.E., Cai H., Drummond G.R., Harrison D.G. Shear stress regulates endothelial nitric oxide synthase expression through c-Src by divergent signaling pathways. Circ. Res. 2001, 89:1073-1080.
51. Weber M., Hagedorn C.H., Harrison D.G., Searles C.D. Laminar shear stress and 3′-polyadenylation of eNOS mRNA. Circ. Res. 2005, 96:1161-1168.
52. Chambliss K.L., Shaul P.W. Estrogen modulation of endothelial nitric oxide synthase. Endocr. Rev. 2002, 23:665-686.
53. Duckles S.P., Krause D.N. Cerebrovascular effects of oestrogen: multiplicity of action. Clin. Exp. Pharmacol. Physiol. 2007, 34:801-808.
54. Simoncini T., Fornari L., Mannella P., Varone G., Caruso A., Liao J.K., Genazzani A.R. Novel non-transcriptional mechanisms for estrogen receptor signaling in the cardiovascular system. Interaction of estrogen receptor α with phosphatidylinositol 3-OH kinase. Steroids 2002, 67:935-939.
55. Kleinert H., Wallerath T., Euchenhofer C., Ihrig-Biedert I., Li H., Förstermann U. Estrogens increase transcription of the human endothelial NO synthase gene: analysis of the transcription factors involved. Hypertension 1998, 31:582-588.
56. Kan W.H., Hsu J.T., Ba Z.F., Schwacha M.G., Chen J., Choudhry M.A., Bland K.I., Chaudry I.H. P38 MAPK-dependent eNOS upregulation is critical for 17beta-estradiol-mediated cardioprotection following trauma-hemorrhage. Am. J. Physiol. Heart Circ. Physiol. 2008, 294:H2627-H2636.
57. Tummala M., Ryzhov V., Ravi K., Black S.M. Identification of the cysteine nitrosylation sites in human endothelial nitric oxide synthase. DNA Cell Biol. 2008, 27:25-33.
58. Fleming I., Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2003, 284:R1-R12.
59. Li H., Förstermann U. Prevention of atherosclerosis by interference with the vascular nitric oxide system. Curr. Pharm. Des. 2009, 15:3133-3145.
60. Violi F., Basili S., Nigro C., Pignatelli P. Role of NADPH oxidase in atherosclerosis. Future Cardiol. 2009, 5:83-92.
61. Adams V., Linke A., Kränkel N., Erbs S., Gielen S., Möbius-Winkler S., Gummert J.F., Mohr F.W., Schuler G., Hambrecht R. Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in patients with coronary artery disease. Circulation 2005, 111:555-562.
62. Spiekermann S., Landmesser U., Dikalov S., Bredt M., Gamez G., Tatge H., Reepschläger N., Hornig B., Drexler H., Harrison D.G. Electron spin resonance characterization of vascular xanthine and NAD(P)H oxidase activity in patients with coronary artery disease: relation to endothelium-dependent vasodilation. Circulation 2003, 107:1383-1389.
63. Ahmad M., Turkseven S., Mingone C.J., Gupte S.A., Wolin M.S., Abraham N.G. Heme oxygenase-1 gene expression increases vascular relaxation and decreases inducible nitric oxide synthase in diabetic rats. Cell Mol. Biol. (Noisy-le-grand) 2005, 51:371-376.
64. Batzlsperger C.A., Achatz S., Spreng J., Riegger G.A., Griese D.P. Evidence for a possible inhibitory interaction between the HO-1/CO- and Akt/NO-pathways in human endothelial cells. Cardiovasc. Drugs Ther. 2007, 21:347-355.
65. Gao L., Mann G.E. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc. Res. 2009, 82:9-20.
66. Schulz E., Jansen T., Wenzel P., Daiber A., Münzel T. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid. Redox Signal. 2008, 10:1115-1126.
67. Förstermann U. Janus-faced role of endothelial NO synthase in vascular disease: uncoupling of oxygen reduction from NO synthesis and its pharmacological reversal. Biol. Chem. 2006, 387:1521-1533.
68. Heiss E.H., Schachner D., Werner E.R., Dirsch V.M. Active NF-E2-related factor (Nrf2) contributes to keep endothelial NO synthase (eNOS) in the coupled state: role of reactive oxygen species (ROS), eNOS, and heme oxygenase (HO-1) levels. J. Biol. Chem. 2009, 284:31579-31586.
69. Sue Y.M., Cheng C.F., Chang C.C., Chou Y., Chen C.H., Juan S.H. Antioxidation and anti-inflammation by haem oxygenase-1 contribute to protection by tetramethylpyrazine against gentamicin-induced apoptosis in murine renal tubular cells. Nephrol. Dial. Transplant. 2009, 24:769-777.
70. Datla S.R., Dusting G.J., Mori T.A., Taylor C.J., Croft K.D., Jiang F. Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress. Hypertension 2007, 50:636-642.
71. Jiang F., Roberts S.J., Datla S., Dusting G.J. NO modulates NADPH oxidase function via heme oxygenase-1 in human endothelial cells. Hypertension 2006, 48:950-957.
72. Wang X., Wang Y., Kim H.P., Nakahira K., Ryter S.W., Choi A.M. Carbon monoxide protects against hyperoxia-induced endothelial cell apoptosis by inhibiting reactive oxygen species formation. J. Biol. Chem. 2007, 282:1718-1726.
73. Turkseven S., Kruger A., Mingone C.J., Kaminski P., Inaba M., Rodella L.F., Ikehara S., Wolin M.S., Abraham N.G. Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H701-H707.
74. Kruger A.L., Peterson S., Turkseven S., Kaminski P.M., Zhang F.F., Quan S., Wolin M.S., Abraham N.G. D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes. Circulation 2005, 111:3126-3134.
75. Ahmad M., Zhao X., Kelly M.R., Kandhi S., Perez O., Abraham N.G., Wolin M.S. Heme oxygenase-1 induction modulates hypoxic pulmonary vasoconstriction through upregulation of ecSOD. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H1453-H1461.
76. Zhang F., Kaide J.I., Rodriguez-Mulero F., Abraham N.G., Nasjletti A. Vasoregulatory function of the heme-heme oxygenase-carbon monoxide system. Am. J. Hypertens. 2001, 14:62S-67S.
77. Morita T., Mitsialis S.A., Koike H., Liu Y., Kourembanas S. Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. J. Biol. Chem. 1997, 272:32804-32809.
78. Sammut I.A., Foresti R., Clark J.E., Exon D.J., Vesely M.J., Sarathchandra P., Green C.J., Motterlini R. Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haem oxygenase-1. Br. J. Pharmacol. 1998, 125:1437-1444.
79. Otterbein L.E., Zuckerbraun B.S., Haga M., Liu F., Song R., Usheva A., Stachulak C., Bodyak N., Smith R.N., Csizmadia E., Tyagi S., Akamatsu Y., Flavell R.J., Billiar T.R., Tzeng E., Bach F.H., Choi A.M., Soares M.P. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Nat. Med. 2003, 9:183-190.
80. Abraham N.G., Kappas A. Pharmacological and clinical aspects of heme oxygenase. Pharmacol. Rev. 2008, 60:79-127.
81. Otterbein L.E., Bach F.H., Alam J., Soares M., Tao Lu H., Wysk M., Davis R.J., Flavell R.A., Choi A.M. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 2000, 6:422-428.